J.L. Bainbridge & Co’s Amgen AMGN Stock Holding History

J.L. Bainbridge & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-906	Closed	-$221K	–	95
2021 Q2	$221K	Sell	906 -94	-9%	-$23.1K	0.03%	87
2021 Q1	$249K	Sell	1,000 -70	-7%	-$16.7K	0.03%	74
2020 Q4	$246K	Hold	1,070	–	–	0.03%	72
2020 Q3	$272K	Buy	1,070 +85	+9%	+$21.1K	0.04%	58
2020 Q2	$232K	Sell	985 -43	-4%	-$9.81K	0.04%	57
2020 Q1	$208K	Sell	1,028 -59	-5%	-$12.9K	0.04%	62
2019 Q4	$262K	Hold	1,087	–	–	0.04%	67
2019 Q3	$210K	Hold	1,087	–	–	0.03%	67
2019 Q2	$200K	Buy	+1,087	New	+$195K	0.03%	68
2019 Q1	–	Sell	-1,252	Closed	-$244K	–	69
2018 Q4	$244K	Hold	1,252	–	–	0.04%	54
2018 Q3	$260K	Buy	+1,252	New	+$247K	0.04%	55

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

J.L. Bainbridge & Co's AMGN Position: Q3 2021 in Review

J.L. Bainbridge & Co sold out of Amgen (AMGN) in Q3 2021, closing a stake of 906 shares — an estimated $221K sold.

J.L. Bainbridge & Co first reported a position in AMGN in Q3 2018 and held it in 11 quarters. The position peaked at $272K in Q3 2020. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

J.L. Bainbridge & Co reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
J.L. Bainbridge & Co sold 906 Amgen shares in Q3 2021, an estimated $221K.
J.L. Bainbridge & Co first reported a position in Amgen in Q3 2018 and held it in 11 quarters.
J.L. Bainbridge & Co's Amgen position peaked at $272K in Q3 2020.
2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on J.L. Bainbridge & Co's 13F filing for Q3 2021, filed 28 Oct 2021.